Table 3.
NLR value in patients with different PSA levels.
| PSA (ug/L) | Histology | No. of patients | Median NLR (IQR) | P |
| <4 | Benign | 7 (1.7%) | 1.34 (1.21–2.94) | .84 |
| Malignant | 6 (2.5%) | 1.76 (1.41–2.85) | ||
| 4- < 10 | Benign | 239 (58.4%) | 1.97 (1.49–2.62) | .29 |
| Malignant | 127 (52.3%) | 1.97 (1.58–2.80) | ||
| 10–20 | Benign | 139 (34.0%) | 1.97 (1.57–2.40) | .34 |
| Malignant | 78 (32.1%) | 2.18 (1.55–2.87) | ||
| >20 | Benign | 24 (5.9%) | 2.18 (1.93–2.46) | .31 |
| Malignant | 32 (13.1%) | 1.98 (1.39–2.47) | ||
| Total | Benign | 409 (100%) | ||
| Malignant | 243 (100%) |